Oliver F. W. James

Oliver F. W. James's AcademicInfluence.com Rankings

Oliver F. W. James

Philosophy

#8285

World Rank

#11634

Historical Rank

Logic

#5323

World Rank

#6714

Historical Rank

philosophy Degrees

Download Badge

Philosophy

Oliver F. W. James's Degrees

PhD Biochemistry Stanford University
Doctorate Medicine Stanford University

Why Is Oliver F. W. James Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Oliver F. W. James's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Steatohepatitis: a tale of two "hits"? (1998) (3951)
Determinants of progression to cirrhosis or fibrosis in pure alcoholic fatty liver (1995) (456)
Natural history of early primary biliary cirrhosis (1996) (402)
Hepatic steatosis: Innocent bystander or guilty party? (1998) (395)
Non-alcoholic steatohepatitis (NASH): a disease of emerging identity and importance. (1998) (373)
Survival and symptom progression in a geographically based cohort of patients with primary biliary cirrhosis: follow-up for up to 28 years. (2002) (312)
Non-alcoholic steatohepatitis: another disease of affluence (1999) (281)
PRIMARY BILIARY CIRRHOSIS: IDENTIFICATION OF TWO MAJOR M2 MITOCHONDRIAL AUTOANTIGENS (1988) (278)
Identification and analysis of the major M2 autoantigens in primary biliary cirrhosis. (1988) (263)
Asymptomatic primary biliary cirrhosis: clinical features, prognosis, and symptom progression in a large population based cohort (2004) (238)
Effects of age and gender on in vitro properties of human liver microsomal monooxygenases (1990) (219)
Familial primary biliary cirrhosis reassessed: a geographically-based population study. (1999) (211)
Development, validation, and evaluation of the PBC-40, a disease specific health related quality of life measure for primary biliary cirrhosis (2005) (209)
The true impact of fatigue in primary biliary cirrhosis: a population study. (2002) (208)
Primary biliary cirrhosis once rare, now common in the United Kingdom? (1999) (206)
A controlled trial of prednisolone treatment in primary biliary cirrhosis. Three-year results. (1992) (195)
CTLA-4 gene polymorphism confers susceptibility to primary biliary cirrhosis. (2000) (176)
Patterns of autoimmunity in primary biliary cirrhosis patients and their families: a population-based cohort study. (2004) (175)
Incidence and prevalence of primary biliary cirrhosis in the city of Newcastle upon Tyne, England. (1997) (172)
A randomized trial of antioxidant therapy alone or with corticosteroids in acute alcoholic hepatitis. (2007) (163)
The geographical distribution of primary biliary cirrhosis in a well‐defined cohort (2001) (162)
Guidelines for selection of patients for liver transplantation in the era of donor-organ shortage (1999) (162)
Hepatocellular carcinoma in primary biliary cirrhosis and its impact on outcomes (1997) (156)
Case–control studies of risk factors for primary biliary cirrhosis in two United Kingdom populations (2010) (154)
Reactivity of primary biliary cirrhosis sera with Escherichia coli dihydrolipoamide acetyltransferase (E2p): characterization of the main immunogenic region. (1990) (151)
The association of age and frailty with paracetamol conjugation in man. (1990) (146)
Validation of a fatigue impact score in primary biliary cirrhosis: towards a standard for clinical and trial use. (2000) (142)
Effects of physical activity and age on mitochondrial function. (1996) (139)
The epidemiology of primary biliary cirrhosis. (2003) (137)
An exploratory population‐based case‐control study of primary biliary cirrhosis (2000) (127)
HLA and interleukin 1 gene polymorphisms in primary biliary cirrhosis: associations with disease progression and disease susceptibility (2001) (119)
The epidemiology of primary biliary cirrhosis in north-east England: an increasingly common disease? (1990) (115)
Mortality and Recovery After Stroke in The Gambia (2003) (112)
Bacterial contamination of the small intestine is an important cause of occult malabsorption in the elderly. (1983) (109)
The geoepidemiology of primary biliary cirrhosis. (1997) (100)
Development of autoimmune hepatitis following liver transplantation for primary biliary cirrhosis (1999) (99)
Osteoporosis in primary biliary cirrhosis revisited (2001) (98)
The RsaI polymorphism of CYP2E1 and susceptibility to alcoholic liver disease in Caucasians: effect on age of presentation and dependence on alcohol dehydrogenase genotype. (1998) (94)
INCIDENCE AND PROGNOSTIC IMPORTANCE OF JAUNDICE AFTER CARDIOPULMONARY BYPASS SURGERY (1983) (93)
Hepatic drug metabolism and ageing. (1990) (91)
Primary biliary cirrhosis: geographical clustering and symptomatic onset seasonality. (1983) (85)
Other clinical studyThe natural history of nonalcoholic fatty liver: A follow-up study (1995) (84)
Primary biliary cirrhosis. Quantitation of autoantibodies to purified mitochondrial enzymes and correlation with disease progression. (1990) (84)
Heterozygotes for HFE mutations have no increased risk of advanced alcoholic liver disease (1998) (83)
Metabolic bone disease in primary biliary cirrhosis at presentation. (1988) (80)
The effect of age on pathways of drug metabolism in human liver. (1984) (78)
Who are the frail elderly? (1988) (73)
T‐cell responses to the components of pyruvate dehydrogenase complex in primary biliary cirrhosis (1995) (72)
Are transient environmental agents involved in the cause of primary biliary cirrhosis? Evidence from space–time clustering analysis (2009) (72)
Symptom development and prognosis in primary biliary cirrhosis: a study in two centers. (1990) (70)
Reduction in incidence of severe paracetamol poisoning (2000) (70)
Cancer risk in primary biliary cirrhosis: a study in northern England (1999) (70)
Pain as a complication of use of opiate antagonists for symptom control in cholestasis. (2003) (67)
Tumour necrosis factor-a promoter polymorphisms in primary biliary cirrhosis (1999) (64)
A study of nutritional deficits of long-stay geriatric patients. (1993) (63)
Primary biliary cirrhosis: contribution of HLA class II allele DR8. (1993) (62)
HLA-DR antigens in primary biliary cirrhosis: lack of association. (1985) (61)
Laxative-induced Diarrhoea: A Continuing Clinical Problem (1974) (60)
The E1 alpha and beta subunits of the pyruvate dehydrogenase complex are M2'd' and M2'e' autoantigens in primary biliary cirrhosis. (1989) (60)
Autoimmune hepatitis in older patients. (1997) (59)
Hepatic drug clearance: the effect of age using indocyanine green as a model compound. (1990) (56)
Drugs and the ageing liver. (1985) (56)
The Adherent Gastric Antral and Duodenal Mucus Gel Layer Thins with Advancing Age in Subjects Infected with Helicobacter pylori (2000) (55)
Helicobacter pylori in vivo causes structural changes in the adherent gastric mucus layer but barrier thickness is not compromised (1998) (54)
OCCUPATIONAL VITILIGO INDUCED BY p-tert-BUTYLPHENOL, A SYSTEMIC DISEASE? (1977) (53)
D-penicillamine for primary biliary cirrhosis. (1985) (51)
No Rise in Incidence but Geographical Heterogeneity in the Occurrence of Primary Biliary Cirrhosis in North East England (2014) (50)
Prospective study of post-transfusion hepatitis after cardiac surgery in a British centre. (1983) (48)
C ASE R EPORT: Oral antioxidant therapy for the treatment of primary biliary cirrhosis: A pilot study (1999) (46)
Clinical features and prognosis of alcoholic liver disease in respect of advancing age. (1987) (45)
Grip strength and subjective fatigue in patients with primary biliary cirrhosis. (2001) (45)
Ageing and duodenal morphometry. (1992) (45)
Platelet associated immunoglobulins in primary biliary cirrhosis: a cause of thrombocytopenia? (1985) (43)
Gastrointestinal responses to oats consumption in young adult and elderly rats: digestion, large bowel fermentation and crypt cell proliferation rates (1993) (43)
Ursodeoxycholic acid treatment for chronic cholestatic liver disease. (1990) (41)
Reduced serum lipoprotein(a) levels in patients with primary biliary cirrhosis. (1994) (41)
Lentil-lectin-reactive alpha-fetoprotein in the differential diagnosis of benign and malignant liver disease. (1986) (40)
Identification and characterization of four M2 mitochondrial autoantigens in primary biliary cirrhosis. (1989) (40)
Induction of remission in hepatocellular carcinoma with a new thymidylate synthase inhibitor, CB3717. A phase II study. (1987) (38)
Cytotoxic T-lymphocyte-associated antigen-4 single nucleotide polymorphisms and haplotypes in primary biliary cirrhosis. (2007) (37)
No specific association between primary biliary cirrhosis and bacteriuria? (1989) (36)
M4 and M9 autoantigens in primary biliary cirrhosis--a negative study. (1993) (35)
Hepatitis C virus infection in the elderly. (1996) (35)
Mitochondrial involvement in the ageing process. Facts and controversies (1997) (34)
Alcohol dehydrogenase polymorphisms and predisposition to alcoholic cirrhosis (1993) (33)
Assessing quality of life in primary biliary cirrhosis. (2004) (33)
Low prevalence of antibody to hepatitis C virus in North East England (1990) (33)
Primary biliary cirrhosis: epidemiology helping the clinician (1996) (32)
Parenchymal liver disease in the elderly (1997) (32)
Non-parenchymal cell responses in paracetamol (acetaminophen)-induced liver injury. (1994) (32)
The effect of age and frailty upon acetanilide clearance in man. (1989) (31)
Tamoxifen: a novel treatment for primary biliary cirrhosis? (2004) (31)
Presentation and mortality of primary biliary cirrhosis in older patients. (2000) (28)
A biphasic illness associated with acute hepatitis A virus infection. (1986) (28)
Human pyruvate dehydrogenase complex as an autoantigen in primary biliary cirrhosis. (1993) (27)
Analysis of H LA-class-li-encoded antigen-processing genes TAP1 and TAP2 in primary biliary cirrhosis (1994) (26)
Tumour necrosis factor-alpha promoter polymorphisms in primary biliary cirrhosis. (1999) (24)
Liver in metabolic diseases (1984) (24)
Transjugular intrahepatic portosystemic shunt: a limited role in refractory ascites (1997) (23)
Is measurement of type III procollagen amino propeptide useful in primary biliary cirrhosis? (1989) (23)
Defining the immunogenetic susceptibility to primary biliary cirrhosis (1994) (23)
Duodenal brush-border mucosal glucose transport and enzyme activities in aging man and effect of bacterial contamination of the small intestine (1993) (22)
The association of age with the activity of alcohol dehydrogenase in human liver. (1992) (22)
Primary biliary cirrhosis: clinical and associated autoimmune features and natural history. (1998) (22)
Gastrointestinal and liver function of old age. (1983) (21)
Metastatic breast carcinoma presenting as acute liver failure and portal hypertension (2002) (21)
A trial of antioxidant therapy alone or with corticosteroids in acute alcoholic hepatitis (2002) (21)
The effect of age on mono-oxygenase enzyme kinetics in rat liver microsomes. (1987) (20)
Portal hypertension secondary to arterio-portal fistulae: two unusual cases. (1999) (20)
The effect of alcoholic cirrhosis on the activities of microsomal aldrin epoxidase, 7-ethoxycoumarin O-de-ethylase and epoxide hydrolase, and on the concentrations of reduced glutathione in human liver. (1983) (20)
Ranitidine increases the bioavailability of postprandial ethanol by the reduction of first pass metabolism. (1995) (20)
A disease of emerging identity and importance (1998) (18)
Liver disease in the elderly. (1994) (18)
Is primary biliary cirrhosis a different disease in the elderly? (1985) (18)
Sequential coronary artery bypass grafting and orthotopic liver transplantation: a case report. (1996) (17)
The failing malignant liver (1998) (15)
Age and the metabolism of drugs. (1987) (14)
Inhibition of the growth of human hepatocellular carcinoma in vitro and in athymic mice by a quinazoline inhibitor of thymidylate synthase, CB3717. (1986) (14)
Epidemiology and genetics of primary biliary cirrhosis. (1990) (14)
No evidence for involvement of type 1 collagen structural genes in 'genetic predisposition' to alcoholic cirrhosis. (1992) (12)
Aspects of nutrition in the elderly. (1985) (12)
Progression of autoimmune damage in primary biliary cirrhosis: an immunohistochemical study. (1989) (11)
Paraproteins in primary biliary cirrhosis. (1986) (11)
Lymphocytes from patients with primary biliary cirrhosis spontaneously secrete high levels of IgG3 in culture. (1988) (11)
Clarification of the identity of the major M2 autoantigen in primary biliary cirrhosis. (1991) (10)
Polymerase chain reaction for detection of the alpha-1-antitrypsin Z allele in chronic liver disease. (1990) (10)
The Canadian multi-center double-blind randomized controlled trial of ursodeoxycholic acid in primary biliary cirrhosis: Heathcote EJ, Cauch-Duder K, Walker V, Bailey RJ, Blendis LM, Ghent CM, Michieletti P, et al. Hepatology 1994;19:1149–1156 (1995) (10)
The Diurnal Profile of Gastric Pepsin Activity Is Reduced with Helicobacter pylori Infection (2004) (10)
Re-evaluation of the metabolism of carbocisteine in a British white population. (1993) (9)
Unsuspected giardiasis as a cause of malnutrition and diarrhoea in the elderly. (1986) (9)
The metabolism of 7-ethoxycoumarin in human liver microsomes and the effect of primary biliary cirrhosis: implications for studies of drug metabolism in liver disease. (1985) (9)
The Lipoate‐Containing Domain of PDC E2 Contains the Main Immunogenic Region of the 70‐kDa M2 Autoantigen in Primary Biliary Cirrhosis (1989) (9)
Positive Antimitochondrial Antibody, Normal Liver Function Tests: Is this Primary Biliary Cirrhosis? (1985) (9)
The Effect of Alcoholic Cirrhosis on the Two Kinetic Components (High and Low Affinity) of the Microsomal O-Deethylation of 7-Ethoxycoumarin in Human Liver (1984) (8)
Other clinical studyT-cell responses to the components of pyruvate dehydrogenase complex in primary biliary cirrhosis☆ (1995) (8)
The acute and subchronic effects of ketoconazole on hepatic microsomal monooxygenases in the rat. (1988) (8)
Hepatocellular carcinoma in north-east England: importance of hepatitis B infection and ex-tropical military service. (1986) (7)
The effect of alcoholic cirrhosis on the two kinetic components (high and low affinity) of the microsomal 0-deethylation of 7-ethoxycoumarin in human liver (2004) (7)
The value of tumour marker kinetics in the management of patients with primary hepatocellular carcinoma (1988) (7)
Dextropropoxyphene induced hepatotoxicity mimicking biliary tract disease. (1986) (7)
Plasma membrane form of phosphatidate phosphohydrolase: a possible role in signal transduction during liver fibrogenesis. (1993) (6)
The relation of age to the acute effects of ethanol on acetanilide disposition. (1989) (6)
Osteoporosis is not a specific complication of primary biliary cirrhosis (PBC) (2000) (6)
Liver function and structure in survivors of acetaminophen poisoning (1977) (6)
M2 AUTOANTIGENS IN PRIMARY BILIARY CIRRHOSIS (1989) (5)
The acute effects of ethanol on acetanilide disposition in normal subjects, and in patients with liver disease. (1982) (5)
Double blind placebo-controlled trial of prednisolone treatment in primary biliary cirrhosis (PBC): A 3 year update (1989) (5)
Genetic evidence supporting the two-hit model of NASH pathogenesis (2002) (5)
Pure alcoholic fatty liver and progression to cirrhosis or fibrosis (1995) (5)
Prospective comparison of three non-invasive tests for pancreatic disease. (1984) (4)
Plasma renin activity during the development of paracetamol (acetaminophen) induced acute renal failure in man. (1979) (3)
Alpha 1-antitrypsin granules in the liver--always important? (1990) (3)
Analysis of HLA-class-II-encoded antigen-processing genes TAP1 and TAP2 in primary biliary cirrhosis. (1994) (3)
The occurence and significance of microaggregates in stored blood (2004) (3)
Is the revised international autoimmune hepatitis group (IAHG) scoring system useful (2001) (2)
Post-transfusion hepatitis after cardiac surgery (1984) (2)
Flumecinol improves pruritus in cholestatic liver disease — A double blind placebo controlled trial (1990) (2)
2,5-Diphenyloxazole as a probe for microsomal mono-oxygenation in human and rat liver. (1985) (2)
A population based study of autoimmunity in primary biliary cirrhosis (PBC) patients and their families: evidence for a shared susceptibility (2001) (2)
Tumour necrosis factor-α promoter polymorphisms in primary biliary cirrhosis (1999) (2)
NASH/NAFLD management. (2002) (2)
Does primary biliary cirrhosis cluster in time? (2015) (2)
Restrictions in the availability of paracetamol have been associated with a sustained reduction in the incidence of paracetamol hepatotoxicity (2001) (2)
Steatohepatitis (NASH and ASH) (2001) (2)
Aging and the Gastrointestinal Tract. (2004) (1)
Alpha-1-antitrypsin genotype — A risk factor for alcoholic cirrhosis? (1991) (1)
Vasculitis in primary biliary cirrhosis--response to prednisolone. (1990) (1)
Primary hepatocellular cancer (1987) (1)
Hepatology: A Textbook of Liver Disease: David Zakim, Thomas D. Boyer, editors; 4th ed.; Elsevier Science; GBP 230.00; ISBN: 0-7216-9051-3; 2003 (2003) (1)
Is Ketogenesis Impaired in Patients with Hepatic Cirrhosis (1983) (1)
Vitamin D receptor (VDR) TaqI polymorphism in primary biliary cirrhosis (PBC) (2001) (1)
The effect of drinking behaviour on quality of life in patients with established alcoholic liver disease (2002) (1)
Serial serum AFP heterogeneity changes in patients with hepatocellular carcinoma during chemotherapy (2004) (1)
The Role of Renin in Acute Tubular Necrosis following Paracetamol (Ace-Taminophin) Overdose in Man (1976) (1)
Genetic susceptibility to primary biliary cirrhosis (PBC): Analysis of chemokine receptor 5 (CCR5) delta32 deletion (2001) (1)
Caspase 8 gene polymorphism is associated with primary biliary cirrhosis (2002) (1)
Iron content of alcoholic fatty liver does not predict progression to fibrotic disease (1998) (0)
Autoimmune hepatitis (AIH): Clinical spectrum of disease defined by revised international autoimmune hepatitis group (IAHG) scoring system (2002) (0)
A placebo controlled randomised crossover trial of oral antioxidant supplementation for fatigue in primary biliary cirrhosis (PBC) (2002) (0)
Pain as a complication of opiate antagonist therapy in cholestasis: A single centre experience (2002) (0)
No Support from Complement Profiles Including in Vivo C3 Activation for Immune Complex Aetiology in the Pathogenesis of Primary Biliary Cirrhosis (1981) (0)
The aging gut: pathophysiology, diagnosis and management (1984) (0)
Case reportMetastatic breast carcinoma presenting as acute liver failure and portal hypertension (2002) (0)
Mono oxygenase enzyme kinetics in rat liver microsomes the effect of age (1987) (0)
Digoxin-like factors in liver disease. (1989) (0)
Detection of the Z antitrypsin (1AT) genotype in chronic liver disease by analysis of amplified DNA sequences (1989) (0)
Multivariate analysis of survival in a large population based cohort of patients with primary biliary cirrhosis (PBC) (2002) (0)
3 P Autoimmune hepatitis (AIH): Clinical spectrum of disease defined by revised international autoimmune hepatitis group (IAHG) scoring system (2002) (0)
SEASONAL VARIATION IN THE DIAGNOSIS OF PRIMARY BILIARY CIRRHOSIS (2011) (0)
Lipoprotein (a) [Lp(a)] levels and primary biliary cirrhosis (PBC) (1993) (0)
Is variation in the incidence of PBC in six adjacent health districts "real" or due to variable diagnostic activity? (1999) (0)
Regulation of the alpha-keto acid dehydrogenase complexes and their involvement in primary biliary cirrhosis. (1989) (0)
Blood ammonia and Helicobacter pylori. (1992) (0)
populations biliary cirrhosis in two United Kingdom control studies of risk factors for primary - Case (2010) (0)
Natural history and demography of primary biliary cirrhosis (1998) (0)
Carbocisteine polymorphism and disease. Author's replies (1992) (0)
Autoimmune hepatitis (AIH), in men (2001) (0)
NON-ALCOHOLIC STEATOHEPATITIS. AUTHORS' REPLY (1999) (0)
Long-term survival in “modern” PBC is significantly better than the Mayo model predicts (2001) (0)
The Use and Validation of a new QOL Scale - the PBC 40 - in Primary Biliay Cirrhosis (2005) (0)
Prognosis of primary biliary cirrhosis (PBC) in a large unselected cohort (2000) (0)
Terlipressin for hepatorenal impairment in alcoholic hepatitis (2000) (0)
Evidence of Spatial variation in risk and clustering in PBC (1999) (0)
Primary biltary cirrhosis (PBC) — A “common” disease in N.E. England (1989) (0)
Liver Diseases in the Elderly (2008) (0)
The burden of alcoholic liver disease (ALD) on a regional referral centre (2001) (0)
7-Ethoxyresorufin deethylase (EROD) in human liver —The effect of alcoholic liver disease (2006) (0)
Selected abstracts from the meeting of the British association for the study of the liver London, U.K., 19 February, 1988 (1988) (0)
The presentation of primary biliary cirrhosis in the elderly (1998) (0)
Restrictions in availability of paracetamol (PAR) have been associatedwith a reduction in the incidence of par induced liver failure (2000) (0)
Histocompatibility Antigens (Including Dr-Loci) in Primary Biliary Cirrhosis (PBC) (1983) (0)
Regulation of human phosphatidate phosphohydrolase in human liver (1991) (0)
Failure to sustain peripheral muscle activity as an aetiological factor for fatigue in primary biliary cirrhosis (PBC) (2001) (0)
Kupffer Cell Phagocytosis in Relation to Bsp Clearance in Liver Disease (1978) (0)
PBC prevalence is increasing. Geographic variations are probably “real” (1998) (0)
5. Bone mass and its determinants in elderly women (1990) (0)
Bile acid sulphotransferase activity in human liver cytosol and the effect of primary biliary cirrhosis and other liver diseases (1993) (0)

This paper list is powered by the following services:

Oliver F. W. James's Academic­Influence.com Rankings

Oliver F. W. James's Degrees

Why Is Oliver F. W. James Influential?

Oliver F. W. James's Published Works

Published Works

Oliver F. W. James's AcademicInfluence.com Rankings